We are live on
!
Find out more
BG
Bellevue Group Portfolio holdings
AUM
$4.2B
1-Year Est. Return
54.85%
This Fund
S&P 500
1 Year Est. Return
+54.85%
AUM
$4.2B
AUM Growth
-$1.07B
(-20%)
Holding
195
Top Buys
| 1 | +$203M | |
| 2 | +$156M | |
| 3 | +$146M | |
| 4 |
Amgen
AMGN
|
+$98.7M |
| 5 |
Viridian Therapeutics
VRDN
|
+$70.3M |
Top Sells
| 1 | +$350M | |
| 2 | +$235M | |
| 3 | +$225M | |
| 4 |
RNAM
Avidity Biosciences
RNAM
|
+$190M |
| 5 |
FOLD
Amicus Therapeutics
FOLD
|
+$153M |
Sector Composition
| 1 | Healthcare | 99.74% |
| 2 | Energy | 0.07% |
| 3 | Technology | 0.06% |
| 4 | Financials | 0.03% |
| 5 | Consumer Discretionary | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tango Therapeutics
TNGX
$5.12B
| $50.2M | 1.19% |
2,400,000
-1,527,670
|
|
||
27
Idexx Laboratories
IDXX
$43.5B
| $50.1M | 1.19% |
89,131
-5,408
|
|
||
28
Ultragenyx Pharmaceutical
RARE
$3.03B
| $49.9M | 1.19% |
2,380,000
+2,377,420
|
|
||
29
DexCom
DXCM
$27.1B
| $49.5M | 1.18% |
788,766
-58,639
|
|
||
|
JBIO
30
Jade Biosciences
JBIO
$1.34B
| $49.2M | 1.17% |
3,501,502
+160,399
|
|
||
31
Edgewise Therapeutics
EWTX
$4.46B
| $48.1M | 1.15% |
1,528,518
|
|
||
32
UnitedHealth
UNH
$389B
| $40.1M | 0.95% |
148,203
-26,966
|
|
||
33
Danaher
DHR
$139B
| $38.3M | 0.91% |
202,164
+7,531
|
|
||
34
Celldex Therapeutics
CLDX
$2.77B
| $38.1M | 0.91% |
1,200,000
-2,417,669
|
|
||
35
ResMed
RMD
$29.1B
| $35.8M | 0.85% |
159,346
-1,868
|
|
||
36
Insulet
PODD
$11B
| $34.3M | 0.82% |
163,656
-23,043
|
|
||
37
Thermo Fisher Scientific
TMO
$191B
| $31.7M | 0.75% |
64,412
-665
|
|
||
38
Eli Lilly
LLY
$1.08T
| $31.2M | 0.74% |
33,932
-71
|
|
||
39
GE HealthCare
GEHC
$29.9B
| $29.7M | 0.71% |
416,887
-7,627
|
|
||
40
Disc Medicine
IRON
$2.86B
| $29.4M | 0.7% |
+459,314
|
|
||
41
Johnson & Johnson
JNJ
$613B
| $29.1M | 0.69% |
119,102
-7,698
|
|
||
42
Annexon
ANNX
$898M
| $28.6M | 0.68% |
5,157,290
|
|
||
43
Cigna
CI
$74.8B
| $26.2M | 0.62% |
98,263
-11,750
|
|
||
|
ORKA
44
Oruka Therapeutics
ORKA
$5.46B
| $24.9M | 0.59% |
+507,008
|
|
||
45
Merck
MRK
$318B
| $24.9M | 0.59% |
206,591
+114,474
|
|
||
46
Align Technology
ALGN
$12.8B
| $23.9M | 0.57% |
139,680
-1,794
|
|
||
47
Steris
STE
$21B
| $22.1M | 0.53% |
99,878
-1,827
|
|
||
48
Globus Medical
GMED
$11.7B
| $21.3M | 0.51% |
247,261
-15,422
|
|
||
49
Monte Rosa Therapeutics
GLUE
$1.88B
| $20.6M | 0.49% |
+1,250,000
|
|
||
50
AbbVie
ABBV
$448B
| $20.3M | 0.48% |
93,567
-41,292
|
|